• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳香化酶抑制剂在重度子宫内膜异位症治疗中的应用

Aromatase inhibitors in the treatment of severe endometriosis.

作者信息

Mousa Noha A, Bedaiwy Mohamed A, Casper Robert F

机构信息

Institute of Medical Science, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

出版信息

Obstet Gynecol. 2007 Jun;109(6):1421-3. doi: 10.1097/01.AOG.0000265807.19397.6d.

DOI:10.1097/01.AOG.0000265807.19397.6d
PMID:17540816
Abstract

BACKGROUND

Endometriosis-associated chronic pelvic pain unresponsive to surgical menopause is a difficult clinical problem.

CASE

A middle-aged woman presented with endometriosis and severe pelvic pain after hysterectomy and bilateral salpingo-oopherectomy. She was first treated with exemestane without improvement of symptoms. However, another aromatase inhibitor, letrozole, relieved her pain, and concomitant treatment with estrogen relieved hot flushes without pain reactivation.

CONCLUSION

Letrozole was superior to exemestane in relieving the endometriosis-associated pain in this postmenopausal woman. This suggests that patients may respond variably to different aromatase inhibitors.

摘要

背景

与子宫内膜异位症相关的慢性盆腔疼痛对手术绝经无反应是一个棘手的临床问题。

病例

一名中年女性在子宫切除和双侧输卵管卵巢切除术后出现子宫内膜异位症和严重盆腔疼痛。她首先接受依西美坦治疗,但症状未改善。然而,另一种芳香化酶抑制剂来曲唑缓解了她的疼痛,同时使用雌激素治疗潮热,且疼痛未复发。

结论

在缓解这名绝经后女性的子宫内膜异位症相关疼痛方面,来曲唑优于依西美坦。这表明患者对不同的芳香化酶抑制剂可能有不同反应。

相似文献

1
Aromatase inhibitors in the treatment of severe endometriosis.芳香化酶抑制剂在重度子宫内膜异位症治疗中的应用
Obstet Gynecol. 2007 Jun;109(6):1421-3. doi: 10.1097/01.AOG.0000265807.19397.6d.
2
Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.芳香化酶抑制剂成功治疗绝经前患者难治性子宫内膜异位症相关慢性盆腔疼痛。
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):112-5. doi: 10.1016/j.ejogrb.2008.12.002. Epub 2009 Feb 23.
3
Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis.来曲唑联合醋酸炔诺酮与单纯醋酸炔诺酮治疗子宫内膜异位症疼痛症状的比较。
Hum Reprod. 2009 Dec;24(12):3033-41. doi: 10.1093/humrep/dep302. Epub 2009 Sep 2.
4
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.使用芳香化酶抑制剂治疗子宫内膜异位症相关疼痛症状:系统评价。
Reprod Biol Endocrinol. 2011 Jun 21;9:89. doi: 10.1186/1477-7827-9-89.
5
Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.来曲唑与醋酸炔诺酮治疗子宫内膜异位症和慢性盆腔疼痛的初步研究。
Fertil Steril. 2004 Feb;81(2):290-6. doi: 10.1016/j.fertnstert.2003.09.029.
6
Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis.来曲唑与仅含去氧孕烯的避孕药联合用于治疗IV期子宫内膜异位症。
Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):222-5. doi: 10.1111/j.1479-828X.2007.00722.x.
7
Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial.来曲唑和醋酸炔诺酮与来曲唑和曲普瑞林治疗子宫内膜异位症相关疼痛症状的疗效比较:一项随机对照试验。
Reprod Biol Endocrinol. 2011 Jun 21;9:88. doi: 10.1186/1477-7827-9-88.
8
Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.绝经后转移性乳腺癌患者在使用非甾体类芳香化酶抑制剂后,依西美坦作为进一步激素治疗的临床评估。
Cancer Invest. 2007 Mar;25(2):102-5. doi: 10.1080/07357900701224789.
9
Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer.芳香化酶抑制剂在绝经后乳腺癌女性辅助治疗中的获益。
MedGenMed. 2005 Aug 24;7(3):20.
10
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor.用芳香化酶抑制剂治疗重度绝经后子宫内膜异位症。
Fertil Steril. 1998 Apr;69(4):709-13. doi: 10.1016/s0015-0282(98)00022-3.

引用本文的文献

1
A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date.一篇关于芳香化酶抑制剂治疗子宫内膜异位症的系统评价的系统评价:迄今为止的证据。
Drug Des Devel Ther. 2023 May 4;17:1329-1346. doi: 10.2147/DDDT.S315726. eCollection 2023.
2
Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Plasma Micro-RNA Expression.利用血浆微小RNA表达改善子宫内膜异位症病理生理学知识的线索
Diagnostics (Basel). 2022 Jan 12;12(1):175. doi: 10.3390/diagnostics12010175.
3
Implications of immune dysfunction on endometriosis associated infertility.
免疫功能障碍对子宫内膜异位症相关性不孕的影响。
Oncotarget. 2017 Jan 24;8(4):7138-7147. doi: 10.18632/oncotarget.12577.
4
Aromatase inhibitors in the treatment of endometriosis.芳香化酶抑制剂在子宫内膜异位症治疗中的应用
Prz Menopauzalny. 2016 Mar;15(1):43-7. doi: 10.5114/pm.2016.58773. Epub 2016 Mar 29.
5
Use of aromatase inhibitors in practice of gynecology.芳香化酶抑制剂在妇科实践中的应用。
J Ovarian Res. 2015 Feb 25;8:4. doi: 10.1186/s13048-015-0131-9.
6
Impact of medical and surgical treatment of endometriosis on the cure of endometriosis and pain.子宫内膜异位症的药物及手术治疗对其治愈及疼痛的影响。
Biomed Res Int. 2014;2014:264653. doi: 10.1155/2014/264653. Epub 2014 Dec 15.
7
Potential role of aromatase inhibitors in the treatment of endometriosis.芳香化酶抑制剂在子宫内膜异位症治疗中的潜在作用。
Int J Womens Health. 2014 Jul 21;6:671-80. doi: 10.2147/IJWH.S34684. eCollection 2014.
8
Current evidence supporting "letrozole" for ovulation induction.支持使用来曲唑进行促排卵的当前证据。
J Hum Reprod Sci. 2013 Apr;6(2):93-8. doi: 10.4103/0974-1208.117166.
9
Aromatase inhibitors for the treatment of endometriosis.芳香酶抑制剂治疗子宫内膜异位症。
Fertil Steril. 2012 Dec;98(6):1370-9. doi: 10.1016/j.fertnstert.2012.08.053. Epub 2012 Sep 19.
10
Endometrial receptivity defects during IVF cycles with and without letrozole.在接受和不接受来曲唑的体外受精周期中子宫内膜容受性缺陷。
Hum Reprod. 2012 Mar;27(3):881-8. doi: 10.1093/humrep/der452. Epub 2012 Jan 13.